[{"id":"a9305ff1-8168-48d4-a6d2-1d32391a5c57","acronym":"","url":"https://clinicaltrials.gov/study/NCT05344664","created_at":"2022-04-25T21:58:10.116Z","updated_at":"2024-07-02T16:36:11.522Z","phase":"Phase 1","brief_title":"Novel GPC3 CAR-T Cell Therapy for Hepatocellular Carcinoma","source_id_and_acronym":"NCT05344664","lead_sponsor":"Peking University","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 positive","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3-CAR-T cells"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 04/14/2022","start_date":" 04/14/2022","primary_txt":" Primary completion: 10/14/2024","primary_completion_date":" 10/14/2024","study_txt":" Completion: 02/01/2025","study_completion_date":" 02/01/2025","last_update_posted":"2022-04-25"}]